Avricore Health (AVCRF) Cash from Discontinued Operations (2019)

Avricore Health (AVCRF) reported Cash from Discontinued Operations of 177774.65 for Q2 2019.

Avricore Health (AVCRF) Cash from Discontinued Operations (2019) Analysis & Trends

Avricore Health (AVCRF) has 1 years of Cash from Discontinued Operations data on file, last reported at 177774.65 in Q2 2019.

  • Cash from Discontinued Operations for Q2 2019 came in at 177774.65, changed N/A year-over-year; the trailing twelve-month figure through Dec 2019 was 177774.65 (changed N/A YoY), and the FY2018 annual result was 242585.52, up 56.68% from the prior year.
  • Cash from Discontinued Operations held at 177774.65 in Q2 2019 per AVCRF's latest filing.
  • Over five years, Cash from Discontinued Operations peaked at 177774.65 in Q2 2019 and troughed at 177774.65 in Q2 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Discontinued Operations (Qtr)
1 Waters 30,529.42 Bn 30,528.96 Bn 1.11 Bn -
2 Thermo Fisher Scientific 183.75 Bn 180.50 Bn 7.74 Bn -
3 Danaher 133.13 Bn 127.43 Bn 3.59 Bn -
4 Idexx Laboratories 46.14 Bn 45.94 Bn 722.74 Mn -
5 Agilent Technologies 38.20 Bn 36.39 Bn 990.00 Mn -
6 Natera 31.50 Bn 30.40 Bn 696.04 Mn -
7 Iqvia Holdings 31.34 Bn 29.36 Bn 1.36 Bn -
8 Illumina 24.51 Bn 23.36 Bn 721.00 Mn -
9 Mettler Toledo International 23.53 Bn 23.47 Bn 555.82 Mn -
10 Avricore Health - - - -

Historic Data

Download Data
DateValue
Jun 30, 2019 177,774.65
Jun 30, 2019 177,774.65